Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Jianbing, Wu"'
Autor:
Yongkang Xu, Jiayu Zeng, Kan Liu, Dan Li, Shenglan Huang, Shumin Fu, Mao Ye, Si Tao, Jianbing Wu
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract Background The relationship between hepatocellular carcinoma (HCC) metastasis and cancer metabolism reprogramming is becoming increasingly evident. Ubiquitin-specific protease 11 (USP11), a member of the deubiquitinating enzyme family, has b
Externí odkaz:
https://doaj.org/article/7ab9ac0dca854a49adf62e6ce27238bd
Autor:
Shumin Fu, Yongkang Xu, Ye Mao, Mengting He, Zhimeng Chen, Shenglan Huang, Dan Li, Yaqin Lv, Jianbing Wu
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Background Hepatic arterial infusion chemotherapy (HAIC) has demonstrated remarkable local therapeutic efficacy in treating patients with large unresectable hepatocellular carcinoma (HCC). Additionally, the combination of lenvatinib and prog
Externí odkaz:
https://doaj.org/article/6838111ecc69472b8ba9a31c88ad094b
Publikováno v:
ACS Omega, Vol 8, Iss 43, Pp 40260-40276 (2023)
Externí odkaz:
https://doaj.org/article/7634b2546628469bbe51ac67485eb509
Autor:
Yi Chen, Shasha Song, Yongfang Wang, Xiaoli Zhang, Jiafen Zhang, Lili Wu, Jianbing Wu, Xinyu Li
Publikováno v:
Arabian Journal of Chemistry, Vol 17, Iss 3, Pp 105612- (2024)
Psoriasis is a common chronic inflammatory skin disease, which has seriously affected human health. Berberine is a plant alkaloid with significant anti-inflammatory effect. In this study, we aimed to determine whether topical application of berberine
Externí odkaz:
https://doaj.org/article/06eb4eea6f054df095daf095b3b1ff3f
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 2653-2672 (2023)
The Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing (CMTM) family, comprising nine members, is involved in the tumorigenesis and progression of various cancers. However, the expression profiles and clinical significance of CM
Externí odkaz:
https://doaj.org/article/507f693e0e5d4566a3e9082aecb0408e
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/b1b8c7ac9f6e4f9c8c0af8458ad48f59
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundThe purpose of the study was to assess the efficacy and safety in patients with advanced hepatocellular carcinoma (HCC) who are undergoing hepatic arterial infusion chemotherapy (HAIC) combined with programmed cell death protein-1 (PD-1) an
Externí odkaz:
https://doaj.org/article/b3b5b6781c934f2eb381d43ef0e5e79a
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundActin-related protein 2/3 complex subunit 5 (ARPC5) is one of the members of actin-related protein 2/3 complex and plays an important role in cell migration and invasion. However, little is known about the expression pattern, prognosis valu
Externí odkaz:
https://doaj.org/article/e100db5e51df4f6f924772dc509deeef
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Background: Ephrins, a series of Eph-associated receptor tyrosine kinase ligands, play an important role in the tumorigenesis and progression of various cancers. However, their contributions to hepatocellular carcinoma (HCC) remain unclear. Thus, we
Externí odkaz:
https://doaj.org/article/077d8bf235834d3498a9e08d161aa719
Autor:
Zhengang Ren, Guoliang Shao, Jie Shen, Li Zhang, Xu Zhu, Weijia Fang, Guoping Sun, Yuxian Bai, Jianbing Wu, Lianxin Liu, Yuan Yuan, Jingdong Zhang, Zhen Li, Ling Zhang, Tao Yin, Jincai Wu, Xiaoli Hou, Qingyu Wang, Jun Zhu, Jia Fan
Publikováno v:
Liver Cancer (2022)
Introduction: Current treatments for patients with previously treated advanced hepatocellular carcinoma (HCC) provide modest survival benefits. We evaluated the safety and antitumor activity of serplulimab, an anti-PD-1 antibody, plus the bevacizumab
Externí odkaz:
https://doaj.org/article/de3e46e3527049b293f73c9390e82b8a